BUY Conviction3/5 Analysis quality75/100 now
The YouTuber suggests Schrodinger Inc. as an AI drug discovery company that supplements its own pipeline development by licensing its software, which helps minimize cash burn. It has numerous collaborations with major pharmaceutical companies, a strong balance sheet, and potential for stock boosts from positive trial news, despite its furthest indication still being in Phase One.
“another key player in AI drug Discovery Schrodinger Inc ticker sdrg at $1.6 billion in market cap Schrodinger is supplementing its own drug Discovery Revenue by licensing out its software which brought in $159 million of the total 216 million Revenue last year.”